Table 2. Clinical and biochemical characteristics of the patient before and after treatment with carnitine (200 mg/kg per day).
Plasma-free carnitine levels (μmol/l) | Plasma total carnitine level (μmol/l) | Hemoglobin level (g/dl) | LVPWd (mm) | IVSd (mm) | |
---|---|---|---|---|---|
Reference | 30–50 | 43–65 | 11–13 | 3.59–7.31 | 4.38–8.00 |
Before treatment | 0 | <1 | 7 | 8.3 (z-score 3.26) | 10.5 (z-score 3.45) |
After 3 months of the treatment | 5 | 8 | 14 | 6.8 (z-score 1.98) | 7.9 (z-score 1.95) |
After 12 months of the treatment | 5 | 8 | 12 | 5.8 (z-score 1.07) | 6.0 (z-score 0.94) |
Abbreviations: IVSd, end-diastolic interventricular septal thickness; LVPWd, end-diastolic left ventricular posterior wall thickness.
Z-scores were calculated from reference.11